Skip to main content

Table 1. Study medication dosing and Copaxone® treatment schedule

From: A window of opportunity trial evaluating intratumoral injection of Copaxone® in patients with percutaneously accessible tumors

Back to article page

Translational Medicine Communications

ISSN: 2396-832X

Contact us